Arcturus Therapeutics In... (ARCT)
NASDAQ: ARCT
· Real-Time Price · USD
19.48
0.25 (1.30%)
At close: Aug 15, 2025, 3:59 PM
19.17
-1.62%
After-hours: Aug 15, 2025, 07:54 PM EDT
Arcturus Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 196.47M | 216.95M | 237.03M | 237.18M | 315.33M | 288.4M | 347M | 311.92M | 323.47M | 327.94M | 391.88M | 237.68M | 283.49M | 319.68M | 370.49M | 413.88M | 433.57M | 466.84M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.25M |
Long-Term Investments | 1.89M | 18.39M | 1.89M | 1.89M | 1.89M | 1.89M | 1.89M | 22.13M | 2.13M | n/a | 2.09M | 2.08M | 2.08M | 131K | 515K | 670K | 920K | 1.25M |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.12M | n/a | n/a | n/a | 2.08M | 2.08M | 2.07M | 107K | 107K |
Receivables | 17.2M | 14.57M | 3.97M | 30.2M | 24.09M | 27.06M | 32.06M | 38.22M | 2.8M | 92.48M | 2.76M | 2.04M | 2.25M | 3.69M | 3.37M | 2.02M | 2.16M | 2.01M |
Inventory | n/a | n/a | n/a | n/a | n/a | 55M | n/a | 35M | 55M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 60.83M | 47.27M | 64.98M | 63.44M | 55M | n/a | 55M | n/a | 58.97M | 4.14M | 8.69M | 6.96M | 5.77M | 3.64M | 5.1M | 5.07M | 2.3M | 1.15M |
Total Current Assets | 274.5M | 278.79M | 305.98M | 330.82M | 347.01M | 375.79M | 386.59M | 393.27M | 385.24M | 424.56M | 403.33M | 246.68M | 291.5M | 327M | 378.96M | 420.97M | 438.04M | 470M |
Property-Plant & Equipment | 32.88M | 34.61M | 36.2M | 37.95M | 39.72M | 41.18M | 40.93M | 42.25M | 43.27M | 44.19M | 44.96M | 44.87M | 43.43M | 12.78M | 11.26M | 10.83M | 9.75M | 10.12M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 34.77M | 52.99M | 38.09M | 39.83M | 41.6M | 43.06M | 42.81M | 64.38M | 45.4M | 46.31M | 47.05M | 46.95M | 45.51M | 14.98M | 13.85M | 13.57M | 10.78M | 11.47M |
Total Assets | 309.27M | 331.79M | 344.07M | 370.65M | 388.61M | 418.85M | 429.4M | 457.65M | 430.65M | 470.86M | 450.39M | 293.63M | 337.01M | 341.99M | 392.81M | 434.54M | 448.81M | 481.47M |
Account Payables | 10.62M | 6.18M | 7.19M | 10.13M | 13.9M | 9.14M | 5.28M | 18.36M | 13.62M | 19.34M | 7.45M | 17.96M | 5.76M | 10.01M | 10.06M | 8.27M | 10.08M | 5.6M |
Deferred Revenue | 11.26M | 15.09M | 21.93M | 26.94M | 44.88M | 74.51M | 47.34M | 40.77M | 51.96M | 46.57M | 28.65M | 10.55M | 26.35M | 53.06M | 43.48M | 57.62M | 18.07M | 17.94M |
Short-Term Debt | n/a | 3.67M | 3.55M | 3.44M | 3.92M | 4.27M | 4.31M | 4.2M | n/a | n/a | 60.66M | 27.7M | 27.02M | 24.26M | 22.47M | 18.48M | 5M | 3.13M |
Other Current Liabilities | 24.63M | 2.68M | 9.75M | 25.53M | 15.9M | 15.16M | 14.19M | -708K | 11.96M | 6.69M | 37.41M | 8.05M | 23.35M | 13.15M | 3.58M | 26.02M | 30.66M | 21.4M |
Total Current Liabilities | 46.52M | 49.41M | 65.49M | 69.46M | 91.72M | 115.43M | 81.99M | 87.68M | 90.34M | 90.13M | 126.98M | 75.85M | 92.74M | 107.31M | 99.54M | 118.24M | 70.77M | 53.33M |
Long-Term Debt | 22.93M | 15M | n/a | 25.99M | n/a | n/a | n/a | 20M | n/a | n/a | n/a | 32.04M | 35.76M | 39.23M | 40.63M | 42.34M | 56.31M | 58.15M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 497K | 976K | 1.29M | 1.73M | 2.8M | 3.68M | n/a | n/a | n/a | 1.39M | 878K | 358K |
Total Long-Term Liabilities | 31.7M | 48.62M | 37.6M | 39.33M | 38.31M | 39.45M | 68.9M | 89.91M | 55.13M | 51.48M | 53.09M | 72.11M | 73.55M | 49.93M | 65.07M | 57.17M | 72.4M | 75.53M |
Total Liabilities | 78.22M | 98.03M | 103.09M | 108.79M | 130.03M | 154.88M | 150.89M | 177.59M | 145.47M | 141.62M | 180.07M | 147.96M | 166.3M | 157.24M | 164.6M | 175.41M | 143.16M | 128.86M |
Total Debt | 22.93M | 42.66M | 28.55M | 29.42M | 30.88M | 31.92M | 30.22M | 51.22M | 32.2M | 33.17M | 90.87M | 94.74M | 98.4M | 69.2M | 67.61M | 47.28M | 61.67M | 68.42M |
Common Stock | 27K | 27K | 27K | 27K | 27K | 27K | 27K | 27K | 27K | 27K | 27K | 26K | 26K | 26K | 26K | 26K | 26K | 26K |
Retained Earnings | -472.06M | -462.88M | -448.81M | -418.8M | -411.9M | -394.68M | -367.87M | -356.16M | -339.94M | -287.39M | -338.14M | -455.49M | -420.22M | -398.66M | -347.49M | -308.83M | -254.74M | -200.16M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | 0.00 | -0.00 | n/a | -0.00 |
Shareholders Equity | 231.05M | 233.76M | 240.98M | 261.87M | 258.58M | 263.97M | 278.51M | 280.06M | 285.18M | 329.25M | 270.31M | 145.67M | 170.72M | 184.75M | 228.21M | 259.13M | 305.65M | 352.61M |
Total Investments | 1.89M | 18.39M | 1.89M | 1.89M | 1.89M | 1.89M | 1.89M | 22.13M | 2.13M | n/a | 2.09M | 2.08M | 2.08M | 131K | 515K | 670K | 920K | 2.5M |